9th INTERNATIONAL CONFERENCE ON CACHEXIA, SARCOPENIA & MUSCLE WASTING

  Pósters presentats al 6^th Cachexia Conference (8-10 diciembre, Milán, 2011).

·      L-carnitine: an adequate supplement for a multi-targeted anti-wasting therapy in cancer. Sílvia Busquets, Roberto Serpe, Míriam Toledo, Angelica Betancourt, Enrica Marmonti, Marcel Orpí, Fabrizio Pin, Eva Capdevila, Clelia Madeddu, Francisco J. López-Soriano, Giovanni Mantovani, Antonio Macciò and Josep M. Argilés.

·      The animal cachexia score (ACASCO): a new tool for the staging of cancer cachexia in experimental animals. Angelica Betancourt, Míriam Toledo, Fabio Penna, David Massa, Francisco J. López‐Soriano, Sílvia Busquets and Josep M. Argilés.

·      The use of formoterol in a multi-targeted  anti-wasting therapy in cancer: benefitial effects upon chemotherapy. Míriam Toledo, Fabio Penna, Angelica Betancourt, David Massa, Marina Mola, Mª Jose Carrera, Juan-Francisco Cano Pérez, Francisco J. López-Soriano, Sílvia Busquets and Josep M. Argilés.

·      Megestrol acetate treatment influences tissue amino acid uptake and incorporation during cancer cachexia. Enrica Marmonti, Míriam Toledo, David Massa, Marina Mola, Francisco J. López-Soriano, Sílvia Busquets and Josep M. Argilés.

·      Low dose formoterol combined with megestrol: a potential therapeutic use in cancer cachexia. Silvia Busquets, Robert W. Gristwood, Francisco Javier López-Soriano and Josep M. Argilés.

·      Erythropoietin administration counteracts adipose tissue depletion in murine cancer cachexia models. Fabio Penna, Silvia Busquets, Fabrizio Pin, Miriam Toledo, Domiziana Costamagna, Angelica Betancourt, Francisco J. López-Soriano, Josep M. Argilés, Paola Costelli.